Fundz

Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer

PUBLIC · RGENOct 02, 2023

Position

President

Company

Repligen Corporation

Olivier Loeillot
WalthamManufacturingBiotechnologyHealthcareBiopharma

Description

WALTHAM, Mass., Oct. 02, 2023 -- Repligen Corporation , a life sciences company focused on bioprocessing technology leadership, today announced that it has appointed 20+ year industry veteran Olivier Loeillot to the newly created position of President and Chief Commercial Officer , effective immediately. Mr

Other recent leadership changes in Healthcare and Biopharma

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Repligen Corporation, and when

A new leader at Repligen Corporation brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Repligen Corporation raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Repligen Corporation, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Repligen Corporation. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Repligen Corporation

Location

41 Seyon Street

Waltham, Massachusetts, United States

About

Repligen Corporation (NASDAQ: RGEN) is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the company see our website at www.repligen.com, and follow us on LinkedIn.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Repligen Corporation changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Olivia
Senior decision-maker at this company
••••••••@••••••••

See Olivia's verified email →

Olivia
Senior decision-maker at this company
••••••••@••••••••

See Olivia's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Repligen Corporation's next move

Learn about Strategic plan

Repligen Corporation changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.